Search results for the GEO ID: GSE21610
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM545657
GPL570
NF-1 Non-Failing Sample 1 sample pairs: none tissue: Myocard vad status: unsupported disease status: none vad: none age: 18 gender: f Gene expression data from non-failing control hearts
GSM545658
GPL570
NF-3 Non-Failing Sample 2 sample pairs: none tissue: Myocard vad status: unsupported disease status: none vad: none age: 40 gender: m Gene expression data from non-failing control hearts
GSM545659
GPL570
NF-7 Non-Failing Sample 3 sample pairs: none tissue: Myocard vad status: unsupported disease status: none vad: none age: 5 gender: m Gene expression data from non-failing control hearts
GSM545660
GPL570
NF-8 Non-Failing Sample 4 sample pairs: none tissue: Myocard vad status: unsupported disease status: none vad: none age: 28 gender: m Gene expression data from non-failing control hearts
GSM545661
GPL570
NF-9 Non-Failing Sample 5 sample pairs: none tissue: Myocard vad status: unsupported disease status: none vad: none age: 64 gender: m Gene expression data from non-failing control hearts
GSM545662
GPL570
NF-10 Non-Failing Sample 6 sample pairs: none tissue: Myocard vad status: unsupported disease status: none vad: none age: 31 gender: m Gene expression data from non-failing control hearts
GSM545663
GPL570
NF-11 Non-Failing Sample 7 sample pairs: none tissue: Myocard vad status: unsupported disease status: none vad: none age: 23 gender: m Gene expression data from non-failing control hearts
GSM545664
GPL570
NF-14 Non-Failing Sample 8 sample pairs: none tissue: Myocard vad status: unsupported disease status: none vad: none age: 23 gender: f Gene expression data from non-failing control hearts
GSM545665
GPL570
VAD-IP-2 Implant Sample 1 sample pairs: 2 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Novacor age: 32 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545666
GPL570
VAD-IP-3 Implant Sample 2 sample pairs: 3 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Thoratec age: 40 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545667
GPL570
VAD-IP-4 Implant Sample 3 sample pairs: 4 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 59 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545668
GPL570
VAD-IP-6 Implant Sample 4 sample pairs: 6 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Novacor age: 44 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545669
GPL570
VAD-IP-7 Implant Sample 5 sample pairs: 7 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Thoratec (iVAD) age: 59 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545670
GPL570
VAD-IP-8 Implant Sample 6 sample pairs: 8 tissue: Myocard vad status: before VAD support disease status: ischemic cardiomyopathy vad: Heartmate I age: 52 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545671
GPL570
VAD-IP-9 Implant Sample 7 sample pairs: 9 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Novacor age: 60 gender: f Gene expression data from patients suffering end-stage heart-failure
GSM545672
GPL570
VAD-IP-10 Implant Sample 8 sample pairs: 10 tissue: Myocard vad status: before VAD support disease status: ischemic cardiomyopathy vad: Novacor age: 66 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545673
GPL570
VAD-IP-12 Implant Sample 9 sample pairs: 12 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: CorAide age: 65 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545674
GPL570
VAD-IP-14 Implant Sample 10 sample pairs: 14 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: DuraHeart age: 55 gender: f Gene expression data from patients suffering end-stage heart-failure
GSM545675
GPL570
VAD-IP-15 Implant Sample 11 sample pairs: 15 tissue: Myocard vad status: before VAD support disease status: ischemic cardiomyopathy vad: Heartmate I age: 67 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545676
GPL570
VAD-IP-16 Implant Sample 12 sample pairs: 16 tissue: Myocard vad status: before VAD support disease status: ischemic cardiomyopathy vad: Novacor age: 52 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545677
GPL570
VAD-IP-17 Implant Sample 13 sample pairs: 17 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: DuraHeart age: 44 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545678
GPL570
VAD-IP-18 Implant Sample 14 sample pairs: 18 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Thoratec age: 63 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545679
GPL570
VAD-IP-21 Implant Sample 15 sample pairs: 21 tissue: Myocard vad status: before VAD support disease status: ischemic cardiomyopathy vad: Novacor age: 63 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545680
GPL570
VAD-IP-22 Implant Sample 16 sample pairs: 22 tissue: Myocard vad status: before VAD support disease status: ischemic cardiomyopathy vad: Incor age: 43 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545681
GPL570
VAD-IP-23 Implant Sample 17 sample pairs: 23 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Novacor age: 16 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545682
GPL570
VAD-IP-24 Implant Sample 18 sample pairs: 24 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 56 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545683
GPL570
VAD-IP-26 Implant Sample 19 sample pairs: 26 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: DuraHeart age: 40 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545684
GPL570
VAD-IP-27 Implant Sample 20 sample pairs: 27 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 59 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545685
GPL570
VAD-IP-28 Implant Sample 21 sample pairs: 28 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 45 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545686
GPL570
VAD-IP-29 Implant Sample 22 sample pairs: 29 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Novacor age: 58 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545687
GPL570
VAD-IP-30 Implant Sample 23 sample pairs: 30 tissue: Myocard vad status: before VAD support disease status: ischemic cardiomyopathy vad: DuraHeart age: 68 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545688
GPL570
VAD-IP-40 Implant Sample 24 sample pairs: 40 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 47 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545689
GPL570
VAD-IP-42 Implant Sample 25 sample pairs: 42 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy (VD) vad: Heartmate I age: 33 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545690
GPL570
VAD-IP-44 Implant Sample 26 sample pairs: 44 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Thoratec (biVAD) age: 50 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545691
GPL570
VAD-IP-45 Implant Sample 27 sample pairs: 45 tissue: Myocard vad status: before VAD support disease status: ischemic cardiomyopathy vad: Heartmate I age: 57 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545692
GPL570
VAD-IP-48 Implant Sample 28 sample pairs: 48 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: Novacor age: 66 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545693
GPL570
VAD-IP-51 Implant Sample 29 sample pairs: 51 tissue: Myocard vad status: before VAD support disease status: dilated cardiomyopathy vad: CorAide age: 29 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545694
GPL570
VAD-IP-57 Implant Sample 30 sample pairs: 57 tissue: Myocard vad status: before VAD support disease status: ischemic cardiomyopathy vad: DuraHeart age: 50 gender: m Gene expression data from patients suffering end-stage heart-failure
GSM545695
GPL570
VAD-HTx-2 Transplant Sample 1 sample pairs: 2 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Novacor age: 32 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545696
GPL570
VAD-HTx-3 Transplant Sample 2 sample pairs: 3 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Thoratec age: 40 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545697
GPL570
VAD-HTx-4 Transplant Sample 3 sample pairs: 4 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 59 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545698
GPL570
VAD-HTx-6 Transplant Sample 4 sample pairs: 6 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Novacor age: 44 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545699
GPL570
VAD-HTx-7 Transplant Sample 5 sample pairs: 7 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Thoratec (iVAD) age: 59 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545700
GPL570
VAD-HTx-8 Transplant Sample 6 sample pairs: 8 tissue: Myocard vad status: after VAD support disease status: ischemic cardiomyopathy vad: Heartmate I age: 52 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545701
GPL570
VAD-HTx-9 Transplant Sample 7 sample pairs: 9 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Novacor age: 60 gender: f Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545702
GPL570
VAD-HTx-10 Transplant Sample 8 sample pairs: 10 tissue: Myocard vad status: after VAD support disease status: ischemic cardiomyopathy vad: Novacor age: 66 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545703
GPL570
VAD-HTx-12 Transplant Sample 9 sample pairs: 12 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: CorAide age: 65 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545704
GPL570
VAD-HTx-14 Transplant Sample 10 sample pairs: 14 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: DuraHeart age: 55 gender: f Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545705
GPL570
VAD-HTx-15 Transplant Sample 11 sample pairs: 15 tissue: Myocard vad status: after VAD support disease status: ischemic cardiomyopathy vad: Heartmate I age: 67 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545706
GPL570
VAD-HTx-16 Transplant Sample 12 sample pairs: 16 tissue: Myocard vad status: after VAD support disease status: ischemic cardiomyopathy vad: Novacor age: 52 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545707
GPL570
VAD-HTx-17 Transplant Sample 13 sample pairs: 17 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: DuraHeart age: 44 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545708
GPL570
VAD-HTx-18 Transplant Sample 14 sample pairs: 18 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Thoratec age: 63 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545709
GPL570
VAD-HTx-21 Transplant Sample 15 sample pairs: 21 tissue: Myocard vad status: after VAD support disease status: ischemic cardiomyopathy vad: Novacor age: 63 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545710
GPL570
VAD-HTx-22 Transplant Sample 16 sample pairs: 22 tissue: Myocard vad status: after VAD support disease status: ischemic cardiomyopathy vad: Incor age: 43 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545711
GPL570
VAD-HTx-23 Transplant Sample 17 sample pairs: 23 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Novacor age: 16 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545712
GPL570
VAD-HTx-24 Transplant Sample 18 sample pairs: 24 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 56 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545713
GPL570
VAD-HTx-26 Transplant Sample 19 sample pairs: 26 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: DuraHeart age: 40 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545714
GPL570
VAD-HTx-27 Transplant Sample 20 sample pairs: 27 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 59 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545715
GPL570
VAD-HTx-28 Transplant Sample 21 sample pairs: 28 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 45 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545716
GPL570
VAD-HTx-29 Transplant Sample 22 sample pairs: 29 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Novacor age: 58 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545717
GPL570
VAD-HTx-30 Transplant Sample 23 sample pairs: 30 tissue: Myocard vad status: after VAD support disease status: ischemic cardiomyopathy vad: DuraHeart age: 68 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545718
GPL570
VAD-HTx-40 Transplant Sample 24 sample pairs: 40 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Heartmate I age: 47 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545719
GPL570
VAD-HTx-42 Transplant Sample 25 sample pairs: 42 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy (VD) vad: Heartmate I age: 33 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545720
GPL570
VAD-HTx-44 Transplant Sample 26 sample pairs: 44 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Thoratec (biVAD) age: 50 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545721
GPL570
VAD-HTx-45 Transplant Sample 27 sample pairs: 45 tissue: Myocard vad status: after VAD support disease status: ischemic cardiomyopathy vad: Heartmate I age: 57 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545722
GPL570
VAD-HTx-48 Transplant Sample 28 sample pairs: 48 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: Novacor age: 66 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545723
GPL570
VAD-HTx-51 Transplant Sample 29 sample pairs: 51 tissue: Myocard vad status: after VAD support disease status: dilated cardiomyopathy vad: CorAide age: 29 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
GSM545724
GPL570
VAD-HTx-57 Transplant Sample 30 sample pairs: 57 tissue: Myocard vad status: after VAD support disease status: ischemic cardiomyopathy vad: DuraHeart age: 50 gender: m Gene expression data from patients suffering end-stage heart-failure after VAD support
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes